127 related articles for article (PubMed ID: 31013221)
21. Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
O'Riordan J; Javed M; Doherty C; Hutchinson M
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):383. PubMed ID: 8158196
[No Abstract] [Full Text] [Related]
22. A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii.
Ackerman BH; Haith LR; Patton ML; Guilday RE; Reigart CL; Stair-Buchmann M
J Burn Care Res; 2013; 34(4):403-12. PubMed ID: 23237825
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
[TBL] [Abstract][Full Text] [Related]
24. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
[TBL] [Abstract][Full Text] [Related]
25. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients.
Deaney NB; Tate H
J Antimicrob Chemother; 1996 May; 37(5):975-86. PubMed ID: 8737147
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
[TBL] [Abstract][Full Text] [Related]
28. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Nakane T; Tamura K; Hino M; Tamaki T; Yoshida I; Fukushima T; Tatsumi Y; Nakagawa Y; Hatanaka K; Takahashi T; Akiyama N; Tanimoto M; Ohyashiki K; Urabe A; Masaoka T; Kanamaru A;
J Infect Chemother; 2015 Jan; 21(1):16-22. PubMed ID: 25239059
[TBL] [Abstract][Full Text] [Related]
29. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus.
Asensi F; Pérez-Tamarit D; Otero MC; Gallego M; Llanes S; Abadia C; Cantó E
Pediatr Infect Dis J; 1989 Dec; 8(12):895. PubMed ID: 2626294
[No Abstract] [Full Text] [Related]
30. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
[TBL] [Abstract][Full Text] [Related]
31. Imipenem/cilastatin-induced acute eosinophilic pneumonia.
Foong KS; Lee A; Pekez M; Bin W
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944380
[TBL] [Abstract][Full Text] [Related]
32. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A
Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
[TBL] [Abstract][Full Text] [Related]
33. Carbapenems in febrile neutropenic patients.
Gaya H
J Antimicrob Chemother; 1997 May; 39(5):667-8. PubMed ID: 9184371
[No Abstract] [Full Text] [Related]
34. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
35. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
Naber KG; Adam D; Bauernfeind A; Hönig E
Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Vazquez JA; González Patzán LD; Stricklin D; Duttaroy DD; Kreidly Z; Lipka J; Sable C
Curr Med Res Opin; 2012 Dec; 28(12):1921-31. PubMed ID: 23145859
[TBL] [Abstract][Full Text] [Related]
37. A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem.
Wu Y; Chen K; Shi Z; Wang Q
Curr Pharm Biotechnol; 2014; 15(8):685-90. PubMed ID: 25051950
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany.
Dietrich ES; Patz E; Frank U; Daschner FD
Infection; 1999; 27(1):23-7. PubMed ID: 10027102
[TBL] [Abstract][Full Text] [Related]
39. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
Pais GM; Marianski S; Valdez K; Melicor RP; Liu J; Rohani R; Chang J; Tong SYC; Davis JS; Scheetz MH
Br J Pharmacol; 2024 Mar; 181(5):670-680. PubMed ID: 37696768
[TBL] [Abstract][Full Text] [Related]
40. Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice.
Grochla I; Ko HL; Beuth J; Roszkowski K; Roszkowski W; Pulverer G
Zentralbl Bakteriol; 1990 Nov; 274(2):250-8. PubMed ID: 2085374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
